AC MF_03195; DC Protein; auto c? TR HAMAP; MF_00596; -; 1; level=0 XX Names: GMP_reduct_type1_euk XX ID GMPR DE RecName: Full=GMP reductase; DE Short=GMPR; DE EC=1.7.1.7; DE AltName: Full=Guanosine 5'-monophosphate oxidoreductase; DE Short=Guanosine monophosphate reductase; case or GN Name=GMPR; end case XX CC -!- FUNCTION: Catalyzes the irreversible NADPH-dependent deamination of GMP CC to IMP. It functions in the conversion of nucleobase, nucleoside and CC nucleotide derivatives of G to A nucleotides, and in maintaining the CC intracellular balance of A and G nucleotides. CC -!- CATALYTIC ACTIVITY: CC Reaction=IMP + NADP(+) + NH4(+) = GMP + 2 H(+) + NADPH; CC Xref=Rhea:RHEA:17185, ChEBI:CHEBI:15378, ChEBI:CHEBI:28938, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58053, ChEBI:CHEBI:58115, CC ChEBI:CHEBI:58349; EC=1.7.1.7; CC -!- SUBUNIT: Homotetramer. case and CC -!- SUBCELLULAR LOCATION: Glycosome. end case CC -!- SIMILARITY: Belongs to the IMPDH/GMPR family. GuaC type 1 subfamily. XX DR PROSITE; PS00487; IMP_DH_GMP_RED; 1; trigger=no DR PROSITE; PS51371; CBS; 0-2; trigger=yes DR Pfam; PF00478; IMPDH; 1; trigger=no DR Pfam; PF00571; CBS; 0-2; trigger=no DR NCBIfam; TIGR01305; GMP_reduct_1; 1; trigger=no DR PIRSF; PIRSF000235; GMP_reductase; 1; trigger=no XX KW Metal-binding KW NADP KW Oxidoreductase KW Potassium KW Purine metabolism case and KW Glycosome KW Peroxisome end case XX GO GO:0003920; F:GMP reductase activity GO GO:0006163; P:purine nucleotide metabolic process XX FT From: GMPR2_HUMAN (Q9P2T1) FT BINDING 26..27 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /ligand_note="ligand shared between two neighboring FT subunits" FT Condition: S-R FT BINDING 129..131 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /ligand_note="ligand shared between two neighboring FT subunits" FT /note="in other chain" FT Condition: D-[IV]-A FT BINDING 180..181 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /ligand_note="ligand shared between two neighboring FT subunits" FT /note="in other chain" FT Condition: [IV]-G FT BINDING 285..286 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /ligand_note="ligand shared between two neighboring FT subunits" FT /note="in other chain" FT Condition: Y-R FT BINDING 314..317 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /ligand_note="ligand shared between two neighboring FT subunits" FT Condition: S-[ATG]-[CI]-[TS] FT BINDING 219..221 FT /ligand="GMP" FT /ligand_id="ChEBI:CHEBI:58115" FT Condition: D-G-G FT BINDING 242..243 FT /ligand="GMP" FT /ligand_id="ChEBI:CHEBI:58115" FT Condition: G-[GN] FT BINDING 268..270 FT /ligand="GMP" FT /ligand_id="ChEBI:CHEBI:58115" FT Condition: G-M-[AS] FT BINDING 286..290 FT /ligand="GMP" FT /ligand_id="ChEBI:CHEBI:58115" FT Condition: [RL]-[AV]-[SAP]-E-G FT ACT_SITE 186 FT /note="Thioimidate intermediate" FT Condition: C FT ACT_SITE 188 FT /note="Proton donor/acceptor" FT Condition: T FT BINDING 181 FT /ligand="K(+)" FT /ligand_id="ChEBI:CHEBI:29103" FT Condition: G FT BINDING 183 FT /ligand="K(+)" FT /ligand_id="ChEBI:CHEBI:29103" FT Condition: G FT BINDING 186 FT /ligand="K(+)" FT /ligand_id="ChEBI:CHEBI:29103" FT Condition: C FT BINDING 189 FT /ligand="K(+)" FT /ligand_id="ChEBI:CHEBI:29103" FT Condition: R FT BINDING 78 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /ligand_note="ligand shared between two neighboring FT subunits" FT /note="in other chain" FT Condition: [KR] FT BINDING 269 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /ligand_note="ligand shared between two neighboring FT subunits" FT /note="in other chain" FT Condition: M FT From: GMPR_LEIMA (Q4QEB3) case FT MOTIF 490..Cter FT /note="Microbody targeting signal" FT Tag: Microbody; Condition: [AS]-K-[ML] end case XX Size: 339-553; Related: None; Template: Q9P2T1; P36959; Q4QEB3; Scope: Eukaryota Fusion: Nter: None Cter: None Duplicate: None Plasmid: None Comments: None XX # Revision 1.11 2023/06/01 //